ArticleEuropean geriatric medicine2026
Femoral neck fracture increases 30-day mortality 16-fold and elevates mortality risk for up to 4 years: a matched cohort study of 3,246 patients.
Article in European geriatric medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
methodsThe study design was a matched cohort study based on prospectively collected registry data from the Danish National Patient Register. Included were all patients presenting with an FNF in the Northern Region of Denmark between 2018 and December 2023. The matched reference population was established with a 1:10 ratio (for each patient with an FNF, we included ten citizens who had not experienced an FNF prior to the inclusion date). Basic characteristics including age, gender, and individual comorbidity status were obtained from all patients and the matched population.
resultsA total of 3246 patients were identified with an FNF during the 6-year study period (mean follow-up 2.6 years). Patients' mean age at the time of fracture was 77.9 (95% CI 77.4-78.4). Male mean age was 74.9 years (95% CI 73.9-75.9). Female mean age was 79.6 years (95% CI 79.1-80.2). Gender distribution was 64% females and 36% males. A total of 761 (23.4%) patients died during the first 12 months after the fracture. Within the first 30 days after fracture, patients with FNFs demonstrated markedly increased mortality compared with the age-, sex-, and comorbidity-matched reference cohort, with a crude 30-day mortality of 10% versus 0.3% and a hazard ratio of 16.1. Cumulative survival curves showed that patients with FNFs had an elevated mortality risk during the first 4 years following fracture, after which survival became nearly comparable between the fracture and matched cohorts.
conclusionThis study demonstrated that FNFs are associated with a markedly elevated short-term mortality risk, with patients experiencing a 16 times higher risk of death within 30 days compared with an age-, gender-, and comorbidity-matched group without an FNF. The excess risk was most pronounced during the first 3-6 months and persisted for up to 4 years before converging with the match group mortality rates.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.